Skip to main content
. 2021 Mar 25;16:2405–2417. doi: 10.2147/IJN.S286896

Figure 3.

Figure 3

Zone of inhibition of ciprofloxacin on different microbial strains. +ve: control (5 µg of CIP), -ve: blank or non-loaded NLCs. (A) Ciprofloxacin loaded nanostructured lipid carrier (CIP-NLC), (B) spray dried CIP-NLC with different chitosan: lipid ratios (C1: NCMP1, C2: NCMP2, C3 NCMP3).